Associated Papers
Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient population.
Arun AS et al.
The Pharmacogenomics Journal, 2025
40044654 (PubMed )
Supplement: 41397_2025_364_MOESM3_ESM.xlsx › Sheet1
ALK alterations in salivary gland carcinomas.
Majewska H et al.
Virchows Archiv : an International Journal of Pathology, 2021
Current Coverage of the mTOR Pathway by Next-Generation Sequencing Oncology Panels.
Seeboeck R et al.
International Journal of Molecular Sciences, 2019
Select a paper to view details